Cambridge Investment Research Advisors, Inc. - NEKTAR THERAPEUTICS ownership

NEKTAR THERAPEUTICS's ticker is NKTR and the CUSIP is 640268108. A total of 270 filers reported holding NEKTAR THERAPEUTICS in Q4 2017. The put-call ratio across all filers is 0.16 and the average weighting 0.3%.

Quarter-by-quarter ownership
Cambridge Investment Research Advisors, Inc. ownership history of NEKTAR THERAPEUTICS
ValueSharesWeighting
Q3 2023$80
+1.3%
134,685
-1.7%
0.00%
Q2 2023$79
-17.7%
136,957
-0.1%
0.00%
Q1 2023$96
-67.9%
137,157
+3.7%
0.00%
-100.0%
Q4 2022$299
-99.8%
132,232
+1184.4%
0.00%
+100.0%
Q2 2021$177,000
-14.1%
10,295
-0.2%
0.00%0.0%
Q1 2021$206,000
+12.6%
10,320
-4.1%
0.00%0.0%
Q4 2020$183,000
-7.1%
10,760
-9.3%
0.00%0.0%
Q3 2020$197,000
-28.4%
11,860
+0.1%
0.00%
-50.0%
Q2 2020$275,000
+21.1%
11,853
-7.0%
0.00%0.0%
Q1 2020$227,000
-20.9%
12,745
-4.2%
0.00%0.0%
Q4 2019$287,000
+7.5%
13,306
-9.1%
0.00%0.0%
Q3 2019$267,000
-48.4%
14,645
+0.9%
0.00%
-60.0%
Q2 2019$517,000
+15.7%
14,520
+9.2%
0.01%
+25.0%
Q1 2019$447,000
+28.8%
13,301
+26.1%
0.00%0.0%
Q4 2018$347,000
-52.1%
10,546
-11.2%
0.00%
-42.9%
Q3 2018$724,000
+209.4%
11,876
+148.2%
0.01%
+250.0%
Q2 2018$234,000
-41.5%
4,784
+27.0%
0.00%
-60.0%
Q1 2018$400,000
+82.6%
3,766
+2.7%
0.01%
+66.7%
Q4 2017$219,0003,6660.00%
Other shareholders
NEKTAR THERAPEUTICS shareholders Q4 2017
NameSharesValueWeighting ↓
Ally Bridge Group (NY) LLC 432,952$1,385,0000.91%
GREAT POINT PARTNERS LLC 447,820$1,433,0000.34%
Birchview Capital, LP 128,000$410,0000.29%
Edgestream Partners, L.P. 1,047,636$3,352,0000.26%
Rhenman & Partners Asset Management AB 550,000$2,068,0000.22%
CM Management, LLC 50,000$160,0000.18%
TANG CAPITAL MANAGEMENT LLC 430,037$1,376,0000.17%
PDT Partners, LLC 307,953$985,0000.15%
Virtus ETF Advisers LLC 72,018$230,0000.09%
ALGERT GLOBAL LLC 476,412$1,525,0000.09%
View complete list of NEKTAR THERAPEUTICS shareholders